Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Clinical trial NCT05558956 · UNKNOWN

Trial details

NCT number: NCT05558956
Sponsor: BAMF Health
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer

Start date: 2022-11-01
Primary completion: 2023-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.